Endevica Bio Stock

Endevica Bio is a biotechnology company that develops drugs to treat cachexia.

Sign up today and learn more about Endevica Bio Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Endevica Bio Stock

Endevica Bio create best-in-class peptide drug candidates with better safety and efficacy properties than other drugs in the same class. Endevica’s technology platform, protected by a family of patents and pending applications, allows for the modification of peptides to perform with improved half-life, oral activity, and the ability to cross the blood-brain barrier.

Funding History

June 2016$1.7M
September 2016$2.3M
January 2023$10.0M


Founder, President & Chief Scientific Officer

Kenneth Gruber

Chief Executive Officer

Jake Halliday


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: